MedPath

Effect of Consumption of Millet based Diet in Patients With NAFLD

Phase 3
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2024/06/068310
Lead Sponsor
ICAR-IIMR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Recently diagnosed consenting adults with NAFL (steatotosis) of any grade with or without features of metabolic syndrome

Exclusion Criteria

Individuals who had been hospitalised with complications of Diabetes mellitus, Chronic Kidney disease, Hypertension in the previous 6 months

Those with intake of antibiotics within last month

Seriously ill and bed ridden patients

Patients with viral hepatitis

Pregnant & lactating women

Patients with significant alcohol consumption

Patients having chronic inflammatory bowel disease or any chronic and autoimmune diseases will be excluded

Patients with NAFLD with associated hypertriglyceridemia that requires administration of statins

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath